You just read:

Compugen Presents New Preclinical Data Demonstrating the Distinctive Features of the PVRIG Pathway in Immuno-Oncology and the Potential of COM701 for Treating Multiple Solid Tumors

News provided by

Compugen Ltd.

18 Jan, 2018, 12:00 GMT